| 000 | 01143 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514035911.0 | ||
| 264 | 0 | _c20030210 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0890-9091 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLogothetis, Christopher J | |
| 245 | 0 | 0 |
_aDocetaxel in the integrated management of prostate cancer. Current applications and future promise. _h[electronic resource] |
| 260 |
_bOncology (Williston Park, N.Y.) _cJun 2002 |
||
| 300 |
_a63-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTaxoids |
| 773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 16 _gno. 6 Suppl 6 _gp. 63-72 |
|
| 999 |
_c12000263 _d12000263 |
||